|
Volumn 46, Issue 5, 2002, Pages 1164-1170
|
Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: Results of a two-year, randomized, double-blind, placebo-controlled trial
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HYDROXYCHLOROQUINE;
METHOTREXATE;
PLACEBO;
SALAZOSULFAPYRIDINE;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
EYE DISEASE;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HEADACHE;
HEART INFARCTION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
NEUTROPENIA;
NONHODGKIN LYMPHOMA;
PNEUMONIA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RASH;
REMISSION;
RHEUMATOID ARTHRITIS;
ADULT;
AGED;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
DOUBLE-BLIND METHOD;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
HYDROXYCHLOROQUINE;
MALE;
METHOTREXATE;
MIDDLE AGED;
SULFASALAZINE;
TREATMENT OUTCOME;
|
EID: 0036096084
PISSN: 00043591
EISSN: None
Source Type: Journal
DOI: 10.1002/art.10228 Document Type: Article |
Times cited : (291)
|
References (23)
|